Akero Therapeutics is a clinical-stage biotech company focused on developing innovative treatments for serious metabolic diseases like MASH. Their lead product candidate, EFX, is currently being tested in multiple Phase 2b and Phase 3 clinical trials for patients with cirrhosis or pre-cirrhotic conditions due to MASH. Headquartered in South San Francisco, Akero aims to address high unmet medical needs through cutting-edge research and development.
Akero Therapeutics is seeking a Quality Assurance (QA) Representative to provide quality oversight and compliance support for Clinical Development and Pharmacovigilance (PV) activities. This role will ensure adherence to Good Clinical Practice (GCP) and Good Pharmacovigilance Practice (GVP) requirements, supporting regulatory submissions and safeguarding patient rights. The QA Representative will collaborate with clinical, regulatory, and CRO teams to deliver high-quality execution of clinical and safety activities.
Akero Therapeutics is a clinical-stage biotech company focused on developing innovative treatments for serious metabolic diseases like MASH. Their lead product candidate, EFX, is currently being tested in multiple Phase 2b and Phase 3 clinical trials for patients with cirrhosis or pre-cirrhotic conditions due to MASH. Headquartered in South San Francisco, Akero aims to address high unmet medical needs through cutting-edge research and development.
Akero Therapeutics